0.0000
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
Total Revenue
69.3130
Cost of Revenue
55.9290
Gross Profit
13.3840
Operating Expense
5,443.0090
Operating Income
-5,429.6250
Other Income Expense
2,315.8450
Net Income Common Stockholders
-4,050.0750
Diluted NI Available to Com Stockholders
-4,050.0750
Basic EPS
-0.10
Diluted EPS
-0.10
Basic Average Shares
32,848.3250
Diluted Average Shares
32,848.3250
Total Operating Income as Reported
-5,429.6250
Total Expenses
5,498.9380
Net Income from Continuing & Discontinued Operation
-3,760.1410
Normalized Income
-5,136.4740
Interest Expense
1,440.8720
Net Interest Income
-1,453.6280
EBIT
-5,429.6250
EBITDA
-3,223.9990
Reconciled Cost of Revenue
55.9290
Reconciled Depreciation
2,205.6260
Net Income from Continuing Operation Net Minority Interest
-3,746.9670
Total Unusual Items Excluding Goodwill
2,315.8450
Total Unusual Items
2,315.8450
Normalized EBITDA
-5,539.8440
Tax Rate for Calcs
0.0004
Tax Effect of Unusual Items
926.3380
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SVA Sinovac Biotech Ltd.
6.47
0.00%
PPCB Propanc Biopharma, Inc.
0.0003
0.00%
TTNP Titan Pharmaceuticals, Inc.
3.3400
-1.18%
BCLI Brainstorm Cell Therapeutics Inc.
2.0200
-3.35%
TLSA Tiziana Life Sciences Ltd
0.8400
+14.13%
MURA Mural Oncology plc
3.8900
+6.58%
SILO Silo Pharma, Inc.
1.7700
+3.51%
MNMD Mind Medicine (MindMed) Inc.
6.93
-1.98%
MRNA Moderna, Inc.
42.25
-2.13%